Retractable Technologies (RVP) AI Stock Analysis

• Market Cap: $25.03M
• Dividend Yield: N/A
• Average Volume (3M): 70.56K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.63
• Revenue Growth: -0.24%
• EPS Growth: 50.45%
• Country: US
• Employees: 221
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): >-0.01
• Shares Outstanding: 29,937,159
• 10 Day Avg. Volume: 50,233
• 30 Day Avg. Volume: 70,555
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: -0.50
• Enterprise Value/Revenue: -0.33
• Enterprise Value/Gross Profit: 4.81
• Enterprise Value/Ebitda: 15.20
• 1Y Price Target: $1.00
• Price Target Upside: 19.05% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 51 Neutral
• Price Target: $1.00 ▲(19.05% Upside)

The overall stock score reflects moderate financial health with significant challenges in profitability and cash flow. Positive technical indicators provide some support, but valuation concerns and negative corporate events weigh heavily on the stock's outlook.

Retractable Technologies Business Overview & Revenue Model

Company Description

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

How the Company Makes Money

Retractable Technologies generates revenue primarily through the sale of its safety medical devices to healthcare providers, hospitals, and distributors. The company’s revenue model is based on direct sales, as well as contracts with healthcare institutions that require bulk purchasing of its products. Key revenue streams include the sale of retractable syringes and other related safety devices. Additionally, RVP engages in partnerships with healthcare organizations and distributors, which help to expand its market reach and enhance its sales capabilities. The company's focus on innovation and compliance with safety regulations further contributes to its earnings by driving demand for its products in a market increasingly concerned with safety and risk management in healthcare settings.

Retractable Technologies Financial Statement Overview

Summary

Retractable Technologies faces challenges with profitability and cash flow generation, despite maintaining a strong balance sheet with low leverage. Revenue growth has been inconsistent, and the company needs to address operational inefficiencies to improve margins and cash flow stability. The financial health is moderate, with potential risks from ongoing losses and cash flow constraints.

Income Statement

Retractable Technologies has experienced significant revenue volatility, with a recent TTM revenue growth of 13.09% following a previous decline. However, profitability metrics are concerning, with negative gross and net profit margins in the TTM period, indicating operational challenges. The EBIT and EBITDA margins have also deteriorated, reflecting ongoing cost pressures.

Balance Sheet

The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.015, indicating minimal leverage risk. However, the negative return on equity in the TTM period suggests inefficiencies in generating returns from shareholders' equity. The equity ratio remains stable, highlighting a solid capital structure.

Cash Flow

Cash flow performance is mixed, with a positive free cash flow growth rate of 10.09% in the TTM period. However, negative operating cash flow and a high free cash flow to net income ratio indicate potential liquidity issues. The company needs to improve its cash generation capabilities to support operations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	38.16M	33.05M	43.60M	94.82M	188.38M	81.86M
Gross Profit	-2.62M	-1.03M	9.11M	28.25M	95.35M	37.01M
EBITDA	-829.42K	4.17M	-1.24M	9.94M	76.44M	27.17M
Net Income	-8.74M	-11.89M	-7.01M	5.08M	56.06M	24.22M
Balance Sheet
Total Assets	147.09M	160.72M	179.67M	195.67M	206.30M	104.97M
Cash, Cash Equivalents and Short-Term Investments	33.05M	44.56M	47.29M	49.38M	42.43M	25.65M
Total Debt	1.07M	1.23M	1.54M	1.82M	2.10M	3.74M
Total Liabilities	70.62M	73.55M	80.38M	89.13M	107.14M	55.09M
Stockholders Equity	76.47M	87.17M	99.29M	106.54M	99.17M	49.88M
Cash Flow
Free Cash Flow	-13.55M	-13.00M	1.91M	-61.95K	-25.57M	-2.05M
Operating Cash Flow	-12.04M	-11.56M	2.77M	16.77M	32.79M	19.00M
Investing Cash Flow	8.78M	3.66M	-10.76M	-31.20M	-63.04M	-19.33M
Financing Cash Flow	-551.50K	-535.43K	941.64K	4.99M	41.84M	11.96M

Retractable Technologies Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.84
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RVP, the sentiment is Positive. The current price of 0.84 is above the 20-day moving average (MA) of 0.82, above the 50-day MA of 0.78, and above the 200-day MA of 0.73, indicating a bullish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 56.59 is Neutral, neither overbought nor oversold. The STOCH value of 46.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RVP.

Retractable Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MHUA	68 Neutral	11.96M	1.22	6.82%	―	-4.99%	-19.11%
RVP	51 Neutral	$25.03M	―	-10.80%	―	-0.24%	50.45%
MLSS	46 Neutral	36.14M	-5.30	-208.80%	―	7.84%	-43.00%
FEMY	44 Neutral	15.47M	-0.42	-816.54%	―	98.61%	-1.98%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Retractable Technologies Corporate Events

Retractable Technologies Reports Q2 2025 Financial Results

On August 14, 2025, Retractable Technologies announced its financial results for the periods ending June 30, 2025. The announcement provides insights into the company’s financial performance, which could impact its operations and industry positioning.

Retractable Technologies Reduces Manufacturing Workforce

On July 23, 2025, Retractable Technologies announced a reduction in its manufacturing workforce. This decision may impact the company’s operations and could have implications for its industry positioning and stakeholders.

Retractable Technologies Settles Lawsuit with Locke Lord LLP

On May 19, 2025, Retractable Technologies, Inc. entered into a Settlement Agreement resolving all claims in a lawsuit against Locke Lord LLP in the 44th District Court of Dallas County, Texas. The lawsuit involved allegations related to legal representation in previous litigation against Becton, Dickinson and Company. The settlement results in Retractable Technologies receiving $1.9 million, dismissing all claims with prejudice, and exchanging mutual releases with the defendants, with no admission of liability or damages by either party.